InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Silvernail Lauren P, 管理人员. Officer active across 4 companies, notably Evolus, Inc.. In total, 12 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €577k. Activity tracked since 10 August 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Silvernail Lauren P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
10,075 股Common Stock - Restricted Stock UnitsSEC:0001225755-26-000002:0
1,439 股0Common StockSEC:0001029142-25-000106:0
5,000 股Common StockSEC:0000950170-24-029447:0
5,000 股0Common StockSEC:0001209191-23-056799:0
16,189 股@ US$13.920248.4% 占其流量Common StockSEC:0001570562-22-000107:0
10,192 股@ US$9.725420.7% 占其流量Common StockSEC:0001570562-22-000083:0
53,571 股0Common StockSEC:0001570562-22-000054:0
14,293 股@ US$11.178530.9% 占其流量Common StockSEC:0001570562-21-000156:0
14,293 股@ US$11.17850.032% mcap16.0% 占其流量Common StockSEC:0001570562-21-000158:0
10,000 股Common StockSEC:0001209191-16-095725:0
1,063 股Common StockSEC:0001209191-16-094531:0
339 股Common StockSEC:0001209191-16-088106:0
12 条申报中的 12 条
About Silvernail Lauren P
SILVERNAIL LAUREN P is Dirigeant. They are associated with Evolus, Inc., Revance Therapeutics, Inc., Dynavax Technologies CORP and Harpoon Therapeutics, Inc. The record shows 12 filings in total, and across the 12 sampled filings, the cumulative sell volume is EUR 577451, with the modal transaction nature listed as Attribution, over the period from 2016-01-04 to 2026-02-10.
